Is a complete AVXL research report available?

No complete published report is available for Anavex Life Sciences Corp. (AVXL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · USD

$2.70

+0.21 (+8.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AVXL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	250.2M
Net income (ttm)	-34.1M
EPS (ttm)	-$0.39
Shares out	92.7M
Volume	1,247,724
Beta	1.14
Price target	$20.0	+640.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -34.1M
EPS (ttm): -$0.39
Market cap: 250.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AVXL indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001314052
Company name	Anavex Life Sciences Corp.
Country	United States
Country code	US
Cusip	032797300
Employees	34
Employees Change	-8%
Employees Change Percent	-19.05
Enterprise value	$120.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0327973006
Last refreshed	2026-07-31
Market cap	$250.2M
Market cap category	Micro-Cap
Price	$2.7
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2836
Symbol	AVXL
Website	https://www.anavex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.73%
FCF yield	-13.72%
P/B ratio	1.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-34.1M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-1M
ROA	-19.5
Roa5y	-22.55
ROCE	-31.69
ROE	-30.78
Roe5y	-36.93
ROIC	-21.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.46%
Cagr15y	-7.85%
Cagr1y	-76.26%
Cagr20y	-5.04%
Cagr3y	-30.17%
Cagr5y	-31.8%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$128.8M
Cash	$127.4M
Current Assets	$128.8M
Current Liabilities	$7.1M
Debt	$0
Equity	$121.7M
Liabilities	$7.1M
Long Term Assets	$-0
Long Term Liabilities	$0
Net Cash	$127.4M
Net Cash By Market Cap	$51.31
Net Cash Growth	10.06%
Net Debt Equity	$-1.05
Tangible Book Value	$121.7M
Tangible Book Value Per Share	$1.31
WACC	10.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.24
Net Working Capital	$-5.7M
Quick ratio	18.18
Working Capital	$121.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.05%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-29.69%
1Y total return	-76.23%
200-day SMA	4.08
3Y total return	-65.95%
50-day SMA	2.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.24%
All Time High	31.5
All Time High Change	-91.43%
All Time High Date	2021-06-28
All Time Low	0.07
All Time Low Change	3,947.98%
All Time Low Date	2006-04-13
ATR	0.15
Beta	1.14
Beta1y	2.93
Beta2y	1.86
Ch YTD	-24.16
High	2.71
High52	12.68
High52 Date	2025-07-31
High52ch	-78.71%
Low	2.51
Low52	2.26
Low52 Date	2026-07-17
Low52ch	19.73%
Ma50ch	3.57%
Premarket Change Percent	3.78
Premarket Price	$2.58
Premarket Volume	2,256
Price vs 200-day SMA	-33.89%
RSI	56.06
RSI Monthly	38.33
RSI Weekly	39.05
Sharpe ratio	-1.25x
Sortino ratio	-1.48
Total Return	-4.05%
Tr YTD	-24.16
Tr15y	-70.65%
Tr1m	3.85%
Tr1w	8.87%
Tr3m	-17.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.07
Operating Income	$-38.4M
Price target	$20
Price Target Change	$641
Price Target Change Top	$641

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89,783,522%
Float Percent	96.88%
Shares Insiders	3.12%
Shares Institutions	43.17%
Shares Out	92,671,758
Shares Qo Q	4.1%
Shares Yo Y	4.05%
Short Float	15.75%
Short Ratio	9.59
Short Shares	15.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-44.7M
Adjusted OCF	-44,676,000
Average Volume	952,423.35x
Bv Per Share	1.31
Ch10y	-29.69
Ch15y	-70.65
Ch1m	3.85
Ch1w	8.87
Ch1y	-76.23
Ch20y	-64.47
Ch3m	-17.18
Ch3y	-65.95
Ch5y	-85.24
Ch6m	-45.01
Change	8.43%
Change From Open	7.57
Close	2.49
Days Gap	0.8
Dollar Volume	3,368,854.8
Earnings Date	2026-07-30
Earnings Time	bmo
EBIT	$-38.6M
EBITDA	$-38.6M
EPS	$-0.39
F Score	2
FCF	$-34.1M
FCF EV Yield	-28.18x
FCF Per Share	$-0.37
Financing CF	45,049,000
Fiscal Year End	September
Founded	2,004
Income Tax	$18,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-30
Last Report Date	2026-03-31
Last Split Date	2015-10-07
Last Split Type	Reverse
Last10k Filing Date	2025-11-25
Ma150	3.49
Ma150ch	-22.57%
Ma20	2.54
Ma20ch	6.51%
Net CF	10,974,000
Next Earnings Date	2026-08-11
Open	2.51
Optionable	Yes
Position In Range	95
Post Close	2.7
Postmarket Change Percent	-0.37
Postmarket Price	$2.69
Pre Close	2.49
Price Date	2026-07-30
Ptbv Ratio	2.04
Relative Volume	1.31x
Share Based Comp	10,601,000
Tr20y	-64.47%
Tr6m	-45.01%
Us State	New York
Volume	1,247,724

Anavex Life Sciences Corp. (AVXL)

Coverage state: Market snapshot only — no published research

Generate the first AVXL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AVXL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AVXL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AVXL

Frequently asked questions